Strategic Oncology KAM – Biosimilars & Market Access

IQVIA Inc; Los Angeles (CA); On-site; USD 180,000 - 200,000; Full time

Benefits offered by this job

Medical coverage

Dental coverage

Vision coverage

Life insurance

401(k) with employer matching

Flexible time off

Job summary

IQVIA Inc. in the United States seeks a Key Account Manager to lead field-based commercialization of Henlius US oncology biosimilars across community practices, IDNs, academic medical centers, and major cancer centers.

You will develop strategic account plans, build trusted relationships with clinicians, administrators, pharmacy leaders, and health-system decision-makers while partnering with Market Access to optimize formulary access and reimbursement.

Qualifications

• Bachelor's Degree required; 7+ years pharma/healthcare sales experience.
• 2+ years oncology sales experience preferred.
• Established relationships within community oncology networks and IDNs.
• Proven ability to manage complex healthcare accounts and meet sales objectives.

Responsibilities

• Develop and execute territory and account business plans aligned with objectives.
• Influence clinicians, administrators, pharmacists, and executives on product value.
• Drive market access, formulary placement, and reimbursement strategies.
• Collaborate with Market Access, Medical Affairs, Marketing, and Operations.
• Deliver customer-centric solutions to enhance patient access and care.
• Meet or exceed sales, revenue, and market-share objectives.

Skills

Oncology sales experience

Relationship building

Cross-functional collaboration

Strategic account planning

Territory management

Travel >60%

Education

Bachelor's Degree

Job description

IQVIA Inc. in the United States seeks a Key Account Manager to lead field-based commercialization of Henlius US oncology biosimilars across community practices, IDNs, academic medical centers, and major cancer centers.

You will develop strategic account plans, build trusted relationships with clinicians, administrators, pharmacy leaders, and health-system decision-makers while partnering with Market Access to optimize formulary access and reimbursement.